A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Extrapulmonary Tuberculosis
Interventions
DIAGNOSTIC_TEST

biomarker analysis

"PAXgene blood for RNA will be collected and stored. Results from these additional examinations are not included in the treatment monitoring of the patient concerned. If M. tuberculosis can be cultivated, strains will be stored for genotyping and whole genome sequencing. Serum biomarkers will be tested using commercially available kits.~In addition, TAM-TB assays will be performed from samples stored at each time-point. For this purpose, PBMCs will be collected and frozen using well-established protocols."

Trial Locations (6)

23845

RECRUITING

Research Center Borstel, Borstel

50937

RECRUITING

University Hospital of Cologne, Cologne

53127

NOT_YET_RECRUITING

University Hospital Bonn, Bonn

69120

RECRUITING

University Hospital Heidelberg, Heidelberg

60590 Frankfurt

NOT_YET_RECRUITING

University Hospital Frankfurt, Frankfurt

20251 Hamburg

RECRUITING

University Hospital Hamburg, Hamburg

All Listed Sponsors
collaborator

University Hospital, Bonn

OTHER

collaborator

Research Center Borstel

OTHER

collaborator

Johann Wolfgang Goethe University Hospital

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

Helmholtz Zentrum München

INDUSTRY

collaborator

University Hospital of Cologne

OTHER

lead

University of Cologne

OTHER